戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  of the 15 patients (80%) were adjusted to a target of 0 pd hyperphoria and 10 degrees incyclotropia
2 d to a low-fat dietary pattern intervention (target of 20% of energy from fat), and 60% were randomly
3 a pre-breakfast self-measured plasma glucose target of 4.0-5.5 mmol/L [72-99 mg/dL]) for 30 weeks.
4 equencing and recombineering to identify the target of a Mycobacterium tuberculosis growth inhibitor,
5                                              Targeting of a constitutively active FoxM1 construct or
6 y have clinical significance, as therapeutic targeting of a signaling pathway such as NG2/CSPG4 may h
7 ble using either A2AR antagonists or genetic targeting of A2AR using shRNA.
8 of this interaction for proper intracellular targeting of ABCD4 and cobalamin cofactor synthesis.
9  knockdown of ATGL, the best-known molecular target of ABHD5, impeded the proliferation and invasion,
10 e of the entire SAGA complex where the major target of activator binding, the 430 kDa Tra1 protein, i
11             As a result, Cyclin E2, a direct target of all these microRNAs is upregulated, promoting
12 add to understanding why Gata6 is a frequent target of amplification in cancers.
13          Herein, we have evaluated the tumor targeting of an anti-PD-L1 adnectin after (18)F-fluorine
14 lusively by multifaceted sRNAs that are both targets of and triggers for other sRNAs.
15 gnal-regulatory protein CD47 and a potential target of anti-cancer immunotherapy.
16 on: the latter a biomarker of senescence and target of anti-senescence therapeutics, or senolytics.
17 bacterial species potentially may qualify as targets of anti-virulence therapy and that ajoene could
18 cells within the lung and their potential as targets of antigen recognition by CD4 T cells.
19 r knockdown assay verified that GCGR was the target of aptamer GR-3.
20                                   A critical target of Aurora B is the N-terminal "tail" domain of He
21 inds proteins and citrullinates them, is the target of autoantibodies in early RA.
22 ic acetylcholine receptor (nAChR) is a major target of autoantibodies in myasthenia gravis (MG), an a
23 suppressed the phosphorylation of downstream targets of AXL signaling such as AKT and P70S6K.
24 biosynthesis of ergosterol in fungi, and the target of azole fungicides.
25                                   We discuss targeting of B cell receptor (BCR) signaling, with empha
26                      Furthermore, intestinal targeting of Baf180 renders mice susceptible to a more a
27 tor tyrosine kinase AXL is a transcriptional target of BCL6 in GBM and mediates partially the regulat
28 lly, the mitosis regulator LIN9 was a direct target of BET proteins that mediated the effects of BET
29       Although in multiple contexts Myc is a target of beta-catenin, our characterization of a cell t
30 , and sensors, and examples of mitochondrial targeting of bioactive compounds.
31             The pectin matrix is the main CW target of Botrytis cinerea, and pectin methylesterificat
32 structure of a conserved epitope that is the target of broadly neutralizing antibodies.
33 d focal adhesion kinase (FAK) as proteolytic targets of calpain in Xenopus laevis spinal cord neurons
34     We next uncovered that HDAC2 is a direct target of cAMP response element-binding protein (CREB) t
35 y reduced expression of Axin2, an endogenous target of canonical Wnt signaling, in the developing pal
36          Here, we report that Brg1 is also a target of casein kinase 2 (CK2), a serine/threonine kina
37 r caspase active sites have hampered precise targeting of caspase-6.
38      Models to better understand how in vivo targeting of CD22 translates to human disease are needed
39                     The efficacy of dichroic targeting of chiral nanostructures for biomedical applic
40                                  The genomic targets of circadian clocks are pervasive and are intima
41 l analyses identified miR-141-3p as a direct target of circRNA_100338.
42 y complex molecules by small interfering RNA targeting of class II transactivator can reduce the capa
43 ization properties of ClC-4 permit regulated targeting of ClC-4 to various endosomal compartment syst
44 sterols in eukaryotic cells and is the major target of clinical drugs for managing fungal pathogens,
45 ic, glucagon-like peptide-1 (GLP-1), and the target of clinical investigation, gastric inhibitory pol
46 id lysophosphatidic acid (LPA) and is a drug target of considerable interest for numerous pathologies
47 ch reveals that mitochondria are a bona fide target of Coxiella effectors and MceA is a complex-formi
48            Using radiotherapy to enhance the targeting of CpG to tumors may help advance this once pr
49 ues to determine the identity of the protein targets of CRMs and their sites of modification.
50                                   Successful targeting of CSCs will therefore be necessary to eradica
51       However the success of the therapeutic targeting of CXCR2 is threatened by our relative lack of
52 r study indicated that CD44 might be a novel target of DACH1 in breast carcinoma.
53 Dipeptidyl peptidase-4, a protease that is a target of diabetes therapies.
54          Our findings demonstrate concurrent targeting of different DNA secondary structures offers a
55 d as a model illustrating how interdependent targeting of different silencing pathways can potentiate
56 As (gRNAs) which determine specific sequence targeting of DNAs.
57 cular and mechanistic evidence that bGP is a target of DTCs.
58 sed on target 35S::MIMICRY172 (MIM172), 35S::TARGET OF EARLY ACTIVATION TAGGED 1 (TOE1)-miR172-resist
59                Here we show that concomitant targeting of EGFR and the nonreceptor tyrosine kinases P
60 lene-responsive transcripts were enriched in targets of EIN3 and ERFs.
61 found that both alpha- and beta-cells become targets of endogenous TH signaling during the larval-to-
62                                  Therapeutic targeting of endothelial FABP4 by siRNA in vivo has anti
63 ty, which allowed us to classify chromosomal targets of epigenetic regulation into (i) single copy an
64 identified TGFbeta as a negatively regulated target of estrogen signaling.
65 tial steps in the Plasmodium life cycle, are targets of existing antimalarials.
66               Some individual biomarkers are targets of existing drugs used to treat mood disorders a
67 h outcomes implicate new pathways as well as targets of existing drugs, including icosapent ethyl and
68  ability of LT-scanner to identify the known targets of FDA-approved kinase inhibitors based on templ
69 2 mutations in BBDS, which amplify nucleolar targeting of FGFR2, activate ribosomal DNA (rDNA) transc
70 s genes, including Sox17, shifts the genomic targeting of Fli1 to favour nearby Sox consensus sites a
71                                              Targeting of FOXO1 therefore provides a potential therap
72 ical autophagy pathway in DCs as a molecular target of Foxp3+ Treg-mediated suppression that leads to
73                          Notably, artificial targeting of Fun30 to DSBs is sufficient to bypass the c
74 eloped a new mouse line that enables genetic targeting of GABA cells in orexin(-/-) mice.
75 eal for the first time a collection of brain targets of Galphat-S-ir neurons, suggesting they might m
76 2 Ser-409 phosphorylation inhibited synaptic targeting of GluK1 because, unlike WT Neto2 and the phos
77                  These findings suggest that targeting of GPX4 may represent a therapeutic strategy t
78                     With direct and repeated targeting of health workers, health facilities, and ambu
79  of addressing hemodynamic and neurohormonal targets of HF therapy.
80 tococcus (GAS) and an antigenically variable target of host immunity.
81 uld be desirable to achieve a more selective targeting of Hsp90-co-chaperone complexes.
82 allelic regulatory activity, and CRISPR/Cas9 targeting of human chondrocytes demonstrates that the re
83                Proof of principle of in vivo targeting of human islets by [(11)C]AZ12204657 was shown
84                        Hilpda proved to be a target of hypoxia-inducible factor 1 (Hif-1) and peroxis
85 K and B lymphocyte kinase (BLK) are relevant targets of ibrutinib in pre-BCR(+) ALL.
86 more progress, with the hope that principled targeting of identified thalamic circuits can be uniquel
87 utes to multiple types of muscle atrophy via targeting of IGF-1 and PI3K(p85alpha), and that suppress
88                   In light of the beneficial targeting of IL-23/12 in patients with IBD, 1,25D appear
89  T cells, indicating that these cells can be targets of IL-33, and gammadelta T cell deficiency reduc
90 ace protein expression than typical oncology targets of immunoPET, can serve as an imaging biomarker
91 ures allow identifying the long-range axonal targets of individual in vivo recorded PTs.
92 thelium, but keratinocytes were the earliest targets of infection and made up 60% of infected cells o
93 and glial cells were identified as principal targets of infection.
94 n social influence has focused mainly on the target of influence (e.g., consumer and voter); thus, th
95  retinopathy progression and should not be a target of inhibitory interventions.
96  These findings identify a new route for the targeting of inner membrane proteins in bacteria and hig
97 B1-mediated CRY1 degradation as an important target of insulin action on glucose homeostasis.
98  insulin signaling pathways and identify new targets of insulin signaling that could serve as potenti
99 al effects on intra-neuronal microtubules, a target of interest due to their potential role in post-o
100 velop high-affinity binders against specific targets of interest.
101  Mecp2 KO neurons provides potentially novel targets of intervention for improving hippocampal functi
102  in Mecp2-deficient neurons, providing novel targets of intervention in Rett syndrome.
103 step in the care cascade enables appropriate targeting of interventions and resources.
104 le diagnostic methods that can enable better targeting of interventions.
105 the nanoparticle characteristics that enable targeting of invasive GBM cells.
106                  In addition, we uncover new targets of investigation in both sexes, which could pote
107 cancer-specific metabolic vulnerability upon targeting of its paralogous isoform ME3.
108 hese results strongly suggest that selective targeting of KDM1A using NCL-1 and NCD-38 is a promising
109 ent) than among those who were assigned to a target of less than 140 mm Hg (standard treatment).
110                 2) systolic BP lowering to a target of <130 mm Hg may reduce the risk of several impo
111 IPK1 and caspase-8 as linearly ubiquitinated targets of LUBAC following TRAIL stimulation.
112 Primary SJL mouse brain endothelial cells (a target of MAV-1 in vivo) infected ex vivo with MAV-1 had
113 eptide in diagnostic imaging and therapeutic targeting of MEMs in solid tumors.
114  (SPON2) as a prominent downstream signaling target of metastasis-associated in colon cancer 1 (MACC1
115 ith a low dose of latrunculin A disrupts the targeting of microtubules to cell-cell junctions.
116 ity lipoprotein levels in humans, as a novel target of miR-146a.
117 , we identified beta-catenin as a new direct target of miR-152.
118 AC2 as a potential, and clinically relevant, target of miR-32.
119 ity, suggesting that vimentin is an indirect target of miR-375.
120 atin (Nnat) as a potential glucose-regulated target of miR-708.
121 alidated as direct and functionally relevant targets of miR-141.
122 ll proliferation and suppressed two relevant targets of miR-146a-5p: STAT1 and IRAK2.
123 t prediction algorithms identified potential targets of miR-146b.
124 s transcriptional co-activators (Crtc1-3) as targets of miR-17, miR-144, and miR-21.
125 eptides 7 and 8 (ilp7 and ilp8) are putative targets of miR-277; RNA immunoprecipitation and a lucife
126 way, Notch1, Notch2, and Jagged 1, as direct targets of miR-34a.
127 studies show that the levels of two putative targets of miR-424 that function in DNA damage repair, C
128  ER+ breast cancer cell lines, to reveal the targets of miR-500a-5p after experimental modulation of
129  We performed in silico analyses to identify targets of MIR122 and chromatin immunoprecipitation quan
130 formed to determine whether IRG1 is a direct target of miR93 revealed that IRG1 is not an miR93 targe
131 n the expression of HOXD10, which is a known target of miRNA-10b.
132                         The platelet surface target of MMP-2 and the mechanism through which it prime
133                        Membrane proteins are targets of most available pharmaceuticals, but they are
134 iosynthetic enzymes are among the downstream targets of mTORC1-SRPK2 signaling.
135 gens identified by serological screening are targets of multifunctional cellular immune responses tha
136         Although ARID1A is the most frequent target of mutations, the mechanism by which its inactiva
137                    The benefit of "precision targeting" of mutations is inherently limited by this co
138 marker for this treatment.Significance: Dual targeting of MYC-regulated homologous recombination and
139                                              Targeting of myeloid-dendritic cell receptor DC-SIGN by
140            We also present evidence that the targets of natural selection change over time, as epista
141       The sigma1 protein is also the primary target of neutralizing antibodies.
142                      These studies defined a target of neutralizing antigenic site on DENV4 targeted
143  particle that mediates the co-translational targeting of newly synthesized proteins to cellular memb
144                  The roles and potential for targeting of NLRP3 inflammasome, caspase-1, and IL-1beta
145 ividual 2A(pro) predict RV genotype-specific targeting of NPC pathways and cargos.
146 ork by Taniguchi et al. (2017) suggests that targets of nuclear HDAC5 mediate the behavioral effects
147                                 They are the targets of numerous widely used drugs, especially in the
148                                          The target of one chicken egg (60g) was reached on the 18(th
149 Plasmodium life cycle and a key intervention target of ongoing efforts to eradicate malaria.
150                 P32-directed intraperitoneal targeting of other anticancer agents and nanoparticles u
151 2/3, as a novel pharmacologically accessible target of our transformed HBECs.
152  APAF-1 apoptosome and XIAP as intracellular targets of P. gingivalis, contributing to the deteriorat
153                           Our data show that targeting of p32 with linTT1 tumor-penetrating peptide i
154               Ferredoxin reductase (FDXR), a target of p53, modulates p53-dependent apoptosis and is
155 ese results demonstrate that NRF2 is a major target of p53-independent tumor suppression by ARF and a
156                    The fusion loop is also a target of pan-flavivirus antibodies that are generated a
157 rgeted for mechanistic study and therapeutic targeting of peanut allergy.
158 uminate strategies for selective therapeutic targeting of PGC1alpha-dependent LRH-1 signaling pathway
159 ugh the activation of energy signaling, both targets of photomorphogenesis action, but the organ deve
160 e-rich element (ARE)-binding protein BRF1, a target of PI3K-Akt.
161                                          The target of pitavastatin, hydroxymethylglutarate coenzyme-
162 icient strategy, accomplishing the selective targeting of point-mutated KRAS in vitro and in vivo.
163             Enhanced expression and membrane targeting of PP2A-C was observed in 5% O2, resulting in
164 s make the robust identification of the true targets of protective immunity ambiguous.
165 d DBP immunogens, we validate that the prime targets of protective immunity are conformational epitop
166                                    Molecular targeting of proteins involved in the endosomal sorting
167            A recurrent emerging theme is the targeting of proteins to subcellular microdomains within
168                               Therefore, the targeting of PSMA has become increasingly important over
169 ocytic recycling requires active mechanistic target of rapamycin (aka mammalian target of rapamycin)
170 ssed 2 serine/threonine kinase and mammalian target of rapamycin (both molecules involved in sensing
171 ition, stress kinase activation, mechanistic target of rapamycin (mTOR) activation, loss of glutamate
172                                  Mechanistic target of rapamycin (MTOR) cooperates with Hedgehog (HH)
173                              The mechanistic target of rapamycin (mTOR) coordinates eukaryotic cell g
174                                  Mechanistic target of rapamycin (mTOR) enhances immunity in addition
175 or pharmacologic inhibition of the mammalian target of rapamycin (mTOR) kinase, promotes glutamate se
176 8a is a novel regulator of the Akt/mammalian target of rapamycin (mTOR) pathway downstream of multipl
177 However, given that the PI3K/Akt/mechanistic target of rapamycin (mTOR) pathway is also known to regu
178 flammatory cells by activating the mammalian target of rapamycin (mTOR) pathway.
179                                  Mechanistic target of rapamycin (mTOR) signaling is necessary to gen
180 NF) receptor TrkB, facilitation of mammalian target of rapamycin (mTOR) signaling pathway and inhibit
181 c acid priming, with NF-kappaB and mammalian target of rapamycin (mTOR) signaling strongly increased.
182                       Further, the mammalian target of rapamycin (mTOR) signaling was implicated as b
183 propionic acid (AMPA) receptor and mammalian target of rapamycin (mTOR) signaling, respectively.
184 ell as manipulations of insulin, mechanistic target of rapamycin (mTOR), AMP-activated protein kinase
185  on the conserved protein kinase mechanistic target of rapamycin (mTOR), existing in two complexes, m
186  correlated with upregulation of mechanistic target of rapamycin (mTOR), proinflammatory, and anti-ap
187 or-associated factor 6 (TRAF6) and mammalian target of rapamycin (mTOR), respectively.
188  both involved in activating the mechanistic target of rapamycin (mTOR).
189 el chemoresistance mediated by the mammalian target of rapamycin (mTOR)/sphingosine-kinase-1 (SK1) pa
190 lower levels of phosphorylation of mammalian target of rapamycin (phospho-mTOR).
191 ting phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR) signaling are being inve
192 re we show that Protein Kinase B-mechanistic Target of Rapamycin (PKB/AKT-mTOR) signaling controls th
193 tween the pheromone response pathway and the target of rapamycin (TOR)-regulated ribosomal biogenesis
194       Finally, there was increased mammalian target of rapamycin complex 1 (mTORC1) activation, which
195 Trex1-deficient cells have reduced mammalian target of rapamycin complex 1 (mTORC1) activity, althoug
196                              The mechanistic target of rapamycin complex 1 (mTORC1) is a central regu
197                                  Mechanistic target of rapamycin complex 1 (MTORC1) is a critical neg
198                              The mechanistic target of rapamycin complex 1 (mTORC1) is a protein kina
199                                The mammalian target of rapamycin complex 1 (mTORC1) kinase promotes c
200                              The mechanistic target of rapamycin complex 1 (mTORC1) protein kinase is
201                         Instead, mechanistic target of rapamycin complex 1 (mTORC1) signal transducti
202 e-activated receptor 1 (PAR-1) and mammalian target of rapamycin complex 1 (mTORC1) signaling.
203 Pase, which binds to and activates mammalian target of rapamycin complex 1 (mTORC1) when GTP loaded.
204            This event requires the mammalian target of rapamycin complex 1 (mTORC1), a signaling path
205 red by T cell help activates the mechanistic target of rapamycin complex 1 (mTORC1), which promotes t
206                                  Mechanistic target of rapamycin complex 1 (TORC1) integrates nutrien
207 scle myostatin expression, reduced mammalian target of rapamycin complex 1 function, and hyperammonem
208 tarate-dependent inhibition of the mammalian target of rapamycin complex 1, and deficiency of autopha
209                   In contrast to mechanistic target of rapamycin complex 1-dependent canonical autoph
210 ereas hypertrophy was dependent on mammalian target of rapamycin complex 1.
211 ibe the relationship between the mechanistic target of rapamycin complex 1/2 protein subunit regulato
212 of Pdcd4 increases the activity of mammalian target of rapamycin complex 2 (mTORC2) and thereby upreg
213                                  Mechanistic target of rapamycin inhibition by either nutrient starva
214                     De novo use of mammalian target of rapamycin inhibitors after kidney transplantat
215  phosphatidylinositol 3-kinase and mammalian target of rapamycin inhibitors in breast cancer, and inh
216                                    Mammalian target of rapamycin inhibitors may confer cardioprotecti
217                                              Target of rapamycin kinase complex 1 (TORC1) regulates P
218 tivity in the nucleus can regulate mammalian target of rapamycin signaling and neuronal growth.
219 ltering both energy production and mammalian target of rapamycin signaling in human liver cancer cell
220 s was required to fully suppress mechanistic target of rapamycin signaling, a known effector of NF1 l
221 ns in the proteins associated with mammalian target of rapamycin signalling were detected in the PFC
222 chanistic target of rapamycin (aka mammalian target of rapamycin) (mTORC1), a master metabolic sensor
223 e measured by the universally conserved TOR (Target of Rapamycin) pathway to balance growth and devel
224 starvation or by inhibition of the mammalian target of rapamycin, enhanced lysosomal clearance of C99
225 d protein kinase B, phosphorylated mammalian target of rapamycin, phosphorylated eukaryotic translati
226 kinase and increased expression of mammalian target of rapamycin, suggesting reduced amino acid catab
227 novel mechanistic insights into simultaneous targeting of receptor-mediated proliferation and cell de
228  phosphatases (PTPs) are thought to be major targets of receptor-activated reactive oxygen species (R
229 ainable Development Goal 3, setting a global target of reducing tobacco use and premature mortality f
230                      One suggested molecular target of resveratrol is eukaryotic topoisomerase II (to
231              Adeno-associated virus-mediated targeting of RGMa to mouse DA neurons showed that overex
232 lyzing activity of PLDalpha1, is a molecular target of RGS1.
233              Finally, we demonstrate that co-targeting of ROS1 and EGFR could potentially offer an ef
234               We identified Hhex as a direct target of RUNX1 and FLT3-ITD stimulation and confirmed h
235 with the identification of mRNA of iNOS as a target of Sal-1 in both human and mice.
236 ons why germ plasm might be neither a direct target of selection nor causally linked to accelerated a
237 mmunization activities (SIAs) continued, the targeting of settlements at high risk for polio transmis
238            It is believed to be the cellular target of several antimycobacterial compounds; however,
239   However, the extent to which a chloroplast target of SIG5 is regulated by light-induced changes in
240         These findings show that p66Shc is a target of Sirt1, uncover a unique Sirt1-regulated lysine
241 -A1, which in turn are revealed as potential targets of SlCBL10.
242                                     However, targeting of somatostatin (SOM)- and vasoactive intestin
243 ubtypes were associated with transcriptional targets of SOX2 or p63.
244  in vitro and in vivo Notably, pharmacologic targeting of SPHK1 or YAP/TAZ was sufficient to inhibit
245                      In turn, pyramidal cell targets of SST(+) neurons showed an increased frequency
246 regions which apparently constitute the main target of stabilizing extra-retinal oculomotor influence
247 reased, we sought to identify the biological target of stolonidiol.
248 ially explicit stochastic models to optimize targeting of surveillance and control resources.
249 prehensively analyse the HDM-derived protein targets of T cell responses in HDM-allergic individuals,
250                           Thus the selective targeting of TH1/TH17 cells could inhibit relapses witho
251 terminant of podocyte injury and a known off target of the anti-CD20 antibody rituximab (RTX).
252 Furthermore, we identify Maf as a downstream target of the CIC-ETV5 axis in this process.
253 confirm that cytokinin biosynthesis is a key target of the common symbiosis pathway.
254 atography experiments identified the primary target of the compounds as the T3SS needle pore protein
255  Finally, we show that Satb1 is a downstream target of the Fgf signalling pathway, linking chromatin
256             Mtb RNA polymerase (RNAP) is the target of the first-line antituberculosis drug rifampin
257 Here we demonstrate that DCs are a principal target of the immune modulating activity of triterpenoid
258 tory neurons in the barrel cortex, the major target of the somatosensory thalamus (VPM), respond to t
259 ing implicated the sphingolipid pathway as a target of the TCAs.
260 ing sensor (ALPS) motif within HOPS Vps41, a target of the vacuolar kinase Yck3, is dispensable for t
261 carce, with a need for the specific cellular targeting of the active transition metals.
262 ape response neuronal circuit, by increasing targeting of the gap junctional protein innexin shaking-
263 hen the evidence base supporting therapeutic targeting of the gut microbiota for brain-gut axis disor
264                       These results advocate targeting of the LGR4/R-spondin interaction as a therape
265 uppression function of p53 in cancer by dual targeting of the negative regulators HDM2 and HDMX.
266 e, we report that genetic or pharmacological targeting of the oncogenic MUC1 subunit MUC1-C is suffic
267 pproximately 6,000 yeast mutants for loss of targeting of the subpopulation marker Pdr16 and identifi
268 s; accordingly, we hypothesize that specific targeting of the tumor microenvironment may constitute a
269       Exosome deficiency uncouples chromatin targeting of the viral polymerase complex and the format
270 xperiments and identify the direct molecular targets of the asparagusic acid tag.
271 tubulin and/or microtubules are the cellular targets of the L-acetate fraction.
272                                Multiple mRNA targets of the miR-290 cluster microRNAs are upregulated
273                                    Predicted targets of the miR-9 cluster suggest a role in regulatin
274 d photoaffinity probes to reveal the protein targets of the peptide in live bacteria via chemical pro
275   Human endothelial cells are initiators and targets of the rejection response.
276                                          The targets of the subjects' violent ideation at baseline we
277 arameters, as well as molecular and efferent targets, of the LH GLP-1R activation were also evaluated
278 on of their scaffolding abilities and direct targeting of their interaction interfaces to modulate GP
279 s control of B cell homeostasis, and it is a target of therapeutic intervention in autoimmune disease
280 d endoscopic features are becoming important targets of therapy.
281 structural insights into the HIV trimer, the target of these quaternary antibodies, has created inval
282                                  Therapeutic targeting of these pathways can prevent an LPS-induced i
283 wth, and provide a rationale for therapeutic targeting of this pathway for treatment of OSC.
284 ssay confirmed that ilp7 and ilp8 are direct targets of this miRNA.
285 ore-operated calcium entry (SOCE) as a novel target of TRPM7 kinase activity.
286 ABPs that competitively bind to inflammatory targets of TTP in both endometriotic and endometrial epi
287 ockin of GFP fusion, we uncovered the global targets of UNC-30 and UNC-55.
288 cipated role of Cln1 in regulating lysosomal targeting of V0a1 and suggest that varying factors adver
289 aring imprinted silica nanoparticles against targets of varying molecular mass (melamine, vancomycin
290 , was identified and validated for selective targeting of VHL-deficient CC-RCC in multiple genetic ba
291 e completely different than their subsequent targets of violent behavior.
292  leads to a significant decrease in membrane targeting of viral components, resulting in the severe l
293 viral latency through cellular SCF E3 ligase targeting of viral replication proteins is a unique form
294 ammalian antiviral immunity including direct targeting of viruses and their individual components, an
295                                Mitochondrial targeting of Vms1 is mediated by its conserved mitochond
296 ibrissal motor cortex, vM1 (a frontal cortex target of vS1), while rats compared the intensity of two
297 )=0.358, permutation-based p=0.039, the gene targets of which were enriched for intracellular signali
298          Therapeutically, the indiscriminate targeting of wild-type and point-mutated transcripts rep
299 he 40S protein eS10 as the primary ribosomal target of ZNF598.
300                     To verify the downstream targets of ZNF804A, a Duolink in situ interaction assay

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top